Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma

Published:2013-11-08 Issue:4 Volume:61 Page:579-586
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Harker-Murray Paul D.¹,Drachtman Richard A.²,Hodgson David C.³,Chauvenet Allen Russell⁴,Kelly Kara M.⁵,Cole Peter David⁶⁷

Affiliation:

1. Division of Pediatric Hematology and Oncology; Midwest Children's Cancer Center; Milwaukee Wisconsin

2. Division of Pediatric Hematology Oncology; Robert Wood Johnson Medical School; New Brunswick New Jersey

3. Radiation Medicine Program; Princess Margaret Cancer Centre; Toronto Ontario

4. Children's Oncology Group; West Virginia University; Charleston West Virginia

5. Division of Pediatric Oncology; Columbia University Medical Center; New York New York

6. Department of Pediatrics; Albert Einstein College of Medicine; Bronx New York

7. Department of Pediatric Hematology/Oncology; The Children's Hospital; Bronx New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24851/fullpdf

Reference47 articles.

1. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy;Nachman;J Clin Oncol,2002

2. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease;Hudson;J Clin Oncol,2004

3. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: The results of P9425;Schwartz;Blood,2009

4. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: A report from the Children's Oncology Group;Kelly;Blood,2011

5. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease;Donaldson;J Clin Oncol,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making;American Society of Clinical Oncology Educational Book;2024-06

2. Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma;Frontiers in Immunology;2023-07-31

3. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma;Pediatric Blood & Cancer;2023-07-28

4. Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma;Frontiers in Oncology;2023-06-27

5. Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children’s oncology center;Annals of Hematology;2023-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3